FDA label 43585b52-5a9c-401c-81e5-a2082a328d94

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
317ec4fb-cff0-461d-9ca0-299527a3686d
SPL ID
43585b52-5a9c-401c-81e5-a2082a328d94
Version
3
Effective date
2024-10-30
Source export date
2026-11-06
Source partition
6
Source file
https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/10387d7618367cd955339e75d48af3d11f99f789153db05c529d9fad6eccc645/drug-label-0006-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 07:18:13

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product Use only as directed. Read and follow all directions and warnings on this carton Do not apply over large areas of the body. Do not use on cut, irritated or swollen skin. Do not use on puncture wounds. Do not bandage or apply local heat (such as heating pads) to the area of use or use with a medicated patch. Do not allow contact with eyes or mucous membranes. Do not use at the same time as other topical analgesics. Discontinue use and consult a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days redness is present irritation develops Flammable keep away from fire or flame If pregnant or breast feeding ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) immediately .

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.